Orchard Venture Partners logo

Orchard Venture Partners

North America, Illinois, United States, Chicago

Description

Orchard Venture Partners is a life sciences investment firm that moves tangible scientific assets into large medical companies.

Investor Profile

Orchard Venture Partners has made 10 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (30%)
  • Series Unknown (30%)
  • Series A (20%)
  • Series C (10%)
  • Grant (10%)

Country Focus

  • United States (80%)
  • United Kingdom (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Energy
  • Oncology
  • Medical
  • Automotive
  • Consulting
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orchard Venture Partners frequently co-invest with?

Par Equity
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 3
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 4
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 3
AgeChem Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
Apjohn ventures
North America, Michigan, United States, Kalamazoo
Co-Investments: 2

What are some of recent deals done by Orchard Venture Partners?

Verlume

Aberdeen, Aberdeen City, United Kingdom

Verlume is an energy management and storage technology firm.

Energy
Series UnknownFeb 2, 2022
Amount Raised: $3,391,127
GUIDEcx

Lehi, Utah, United States

GUIDEcx is your Guide for everything customer onboarding. The leader in implementations since 2017.

AutomotiveConsultingEducationFinanceFinancial ServicesHealth CareProfessional ServicesProject Management
Series ANov 12, 2020
Amount Raised: $10,000,000
Verlume

Aberdeen, Aberdeen City, United Kingdom

Verlume is an energy management and storage technology firm.

Energy
Series UnknownApr 20, 2020
Amount Raised: $1,990,793
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series BApr 26, 2011
Amount Raised: $22,000,000
Base4 Biotechnology

Durham, North Carolina, United States

Harnessing atomic-scale biochemistry, quantum physics, and AI for RNA-targeted drug discovery and development.

BiotechnologyPharmaceuticalTherapeutics
GrantJan 1, 2010
Amount Raised: $2,790,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series AJul 28, 2009
Amount Raised: $25,000,000
Logical Therapeutics

Waltham, Massachusetts, United States

Logical Therapeutics develops drugs for the treatment of diseases caused by or related with excessive inflammation.

BiotechnologyHealth CareMedical
Series BJun 13, 2007
Amount Raised: $30,000,000
Kereos

Saint Louis, Missouri, United States

Kereos is a biotechnology company developing molecular imaging agents and therapeutics to treat cancer and cardiovascular diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BSep 20, 2005
Amount Raised: $19,500,000
Sierra Oncology

San Mateo, California, United States

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series UnknownMar 14, 2005
Amount Raised: $1,125,000